Merck & Co

Merck & Co., Inc. (NYSE: MRK), also known as Merck Sharp & Dohme or MSD outside the United States and Canada, is one of the largest pharmaceutical companies in the world. The headquarters of the company is located in Whitehouse Station, New Jersey, an unincorporated area in Readington Township. The company was established in 1891 as the United States subsidiary of the German company now known as Merck KGaA. In common with many other German assets in the United States, Merck & Co. was confiscated in 1917 during World War I and then set up as an independent company. Currently, it is one of the seven largest pharmaceutical companies in the world both by market capitalization and revenue.

Source: Wikipedia

Campaign Finance

Information

Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:

  • contributions under $200 are not reported, and so are not included in totals.
  • only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
  • contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
  • corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
  • organization totals include known subsidiaries of the organization.

For more information, please see our campaign finance methodology page. Lobbyist bundling data is described on our lobbyist bundling methodology page.

Latest FEC Data

covers through committee's May 31, 2012 filing.
Download all contributions to Merck & Co

  • Summary

    overview of the committee's finances
    Total Raised:
    $1,436,786
    Total Spent:
    $1,309,644
    Cash on Hand:
    $462,721
    Debts:
    $0

Standardized Donation Information

covers through 2011. may lag behind FEC section above, as donors and industries are identified by hand.

  • Top Recipients

    Employee Color Block
    Individuals
    PAC Color Block
    PAC
    Includes contributions from the organization’s employees, their family members, and its political action committee.

  • Republicans vs. Democrats

    in dollars. "Other" includes 3rd parties and organizations without official party affiliation.

  • State vs. Federal

    in dollars

  • Top PAC Recipients

    Employee Color Block
    Individuals
    PAC Color Block
    PAC
    Includes contributions from the organization’s employees, their family members, and its political action committee.
View all campaign finance data for Merck & Co Sources: OpenSecrets.org FollowTheMoney.org

Lobbying

$7,125,000 Spent
Information

Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.

For more information, please see our lobbying methodology page.

covers through Q3, 2011

Lobbying On Behalf of Merck & Co

View all lobbying data for Merck & Co Sources: Lobbyist Registration Tracker OpenSecrets.org

Regulations

11 Mentions; 6 Submissions
Information

All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.

Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.

Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.

Regulations and public comments can be downloaded in bulk here.

updated from Regulations.gov on September 27, 2011

The tables show occurrences of "Merck & Co" in public comments on proposed federal regulations.

  • Documents Submitted by the Organization
    • Submissions
    • Agency
    • Docket
    • Date
    • Toggle 1 FDA Draft Guidance for Industry on Non-Penicillin Beta-Lactam Risk Assessment: A CGMP Framework; Availability 2011
    • Toggle 1 FDA Draft Guidance for Industry and FDA Staff: Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Availability 2011
    • Toggle 1 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; Electronic Records; Electronic Signatures 2011
    • Toggle 1 FDA International Conference on Harmonisation; Draft Guidance on Q11 Development and Manufacture of Drug Substances; Availability 2011
    • Toggle 1 FDA Agency Information Collection Activities; Proposals, Submissions, and Approvals: Certification to Accompany Drug, Biological Product, and Device Applications or Submissions 2011
    • Toggle 1 FDA Biologics Price Competition and Innovation Act of 2009; Options for a User Fee Program for Biosimilar and Interchangeable Biological Product Applications for Fiscal Years 2013 through 2017; Request for Comments 2011
  • Mentions in Document Text
    • Mentions
    • Agency
    • Docket
    • Date
    • Toggle 2 FDA International Conference on Harmonisation; Draft Guidance on Q11 Development and Manufacture of Drug Substances; Availability 2011
    • Toggle 1 FDA Periodic Review of Existing Regulations; Retrospective Review Under Executive Order 13563 2011
    • Toggle 1 FDA Agency Information Collection Activities; Proposals, Submissions, and Approvals: Certification to Accompany Drug, Biological Product, and Device Applications or Submissions 2011
    • Toggle 1 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; Electronic Records; Electronic Signatures 2011
    • Toggle 1 EPA NESHAP for Secondary Lead Smelting Amendments Based on the Risk and Technology Review 2011
    • Toggle 1 EPA Toxicological Review of n-Butanol: In Support of Summary Information on the Integrated Risk Information System (IRIS) 2011
    • Toggle 1 FDA Requesting Use of Advice From IOM Committee That Fails to Comply With FACA's Fair Blance Reqirement 2011
    • Toggle 1 CMS Medicare & Medicaid: Influenza Vaccination Standard for Certain Medicare & Medicaid Participating Providers and Suppliers 2011
    • Toggle 1 EPA NJ Regional Haze Program 2011
    • Toggle 1 FDA Draft Guidance for Industry and FDA Staff: Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Availability 2011

Contractor Misconduct

5 Instances
Information

This information is collected by the Project On Government Oversight from press releases, court documents, news reports and other public records. It is not meant to be an exhaustive account of all instances of federal contractor misconduct.

More information on each instance, including primary source documents, is available on POGO's site by clicking on the instance description. More information on POGO's methodology is available here.

covers through POGO's March 3, 2012 release
Misconduct Type Hired By Incident Year Disposition Penalty
Health None Nationwide Vioxx Joint Civil-Criminal Settlement (Civil) 2011 Settlement $628,364,000
Health None Nationwide Vioxx Joint Civil-Criminal Settlement (Criminal) 2011 Settlement $321,636,000
Antitrust None Inflated Drug Prices (Massachusetts Lawsuit) 2011 Settlement $24,000,000
Antitrust None Defrauding Louisiana's Medicaid Program 2012 Settlement $5,000,000
Environment None Environmental Violations at Pennsylvania Pharmaceutical Plants 2011 Fine $1,500,000
View all contractor misconduct data for Merck & Co Sources: Federal Contractor Misconduct Database from POGO

Advisory Committees

2 people on 2 committees
Information

Data is based on disclosures required by the Federal Advisory Committee Act (FACA). Matches are based on the occurrence of the company name in the committee member affiliation. Variations in company names may cause some matches to be missed.

The table shows only the top 10 agencies. To search and download raw records from the complete dataset see the FACA data section.

covers through 2011

Table shows employees of "Merck & Co" that sat on federal advisory committees.

  • Agency
  • Representation
  • Toggle Department of Health and Human Services 2 people on 2 committees
View all advisory committee data for Merck & Co